Larotrectinib Sulfate Oral Solution Instructions for Use

Update: 30 October, 2023

Larotrectinib Sulfate Oral Solution is indicated for the treatment of adult and pediatric patients with solid tumors that are: diagnosed by a validated assay as having a neurotrophic tyrosine receptor kinase (NTRK) fusion gene and do not include known acquired resistance mutations; have locally advanced, metastatic, or unresectable disease or disease that may result in serious complications from surgery; and have no satisfactory alternative treatments or have failed prior therapies.

---

File format: PDF

Size: -

MD5 Checksum: A45EE31F720C3629C2CEE4BD2DF08D7C

Publication date: 30 October, 2023

Downloads: -

PDF Link: Larotrectinib Sulfate Oral Solution Instructions for Use PDF